Francesca Zerbini
Medico Specialista in Diabetologia ed Endocrinologia
Curriculum Vitae
La Dr.ssa Zerbini ha conseguito la Laurea Magistrale a Ciclo unico in Medicina e Chirurgia presso l'Università degli Studi di Pavia con lode nel 2011 e nel 2018, presso lo stesso ateneo, ha ottenuto il diploma di Specializzazione Medica in Endocrinologia e Malattie del Metabolismo, con il massimo dei voti e lode. Nel 2012 ha, inoltre, conseguito il Diploma di Licenza presso l'istituto di Studi Superiori di Pavia (IUSS-Scuola ad ordinamento normale) con votazione eccellente.
Negli anni della formazione specialistica presso la scuola pavese di stampo pisano del Prof. Chiovato, ha maturato particolare interesse ed esperienza nella gestione della patologia tiroidea benigna e maligna. Attualmente svolge la propria attività in regime di collaborazione libero professionale presso il Policlinico di Monza e presso poliambulatori del territorio. La Dr.ssa Zerbini svolge attività ambulatoriale di Endocrinologia con particolare interesse per la patologia nodulare tiroidea, esecuzione di agoaspirato ecoguidato tiroideo, diagnosi e follow-up del carcinoma differenziato tiroideo, patologia autoimmunitaria della tiroide, patologia tiroidea in gravidanza e postpartum. Svolge inoltre attività ambulatoriale diabetologica: diagnosi, terapia, monitoraggio a lungo termine delle complicanze diabete relate in un'ottica di prevenzione cardio-renale.
Da luglio 2022 collabora con l'Ambulatorio di Diabetologia ed Endocrinologia della Clinica Nova Lux polispecialistica di Meda
Prenota online
Seleziona la data e l'ora più comoda per te
Pubblicazioni
- Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes.
Ciardullo S, Muraca E, Cannistraci R, Manzoni G, Perra S, Bianconi E, Oltolini A, Zerbini F, Grassi G, Mancia G, Lattuada G, Perseghin G.Nutr Metab Cardiovasc Dis. 2021 May 6;31(5):1494-1500. doi: 10.1016/j.numecd.2021.01.022. Epub 2021 Feb 6.PMID: 33810954
- An unexpected bilateral mass after total thyroidectomy.
Cannistraci R, Bonacina E, Garbellini A, Muraca E, Ciardullo S, Manzoni G, Mattavelli F, Perseghin G, Zerbini F. Endocrine. 2021 Sep;73(3):758-761. doi: 10.1007/s12020-021-02658-5. Epub 2021 Feb 25.PMID: 33630245 No abstract available.
- Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment.
Muraca E, Ciardullo S, Perra S, Zerbini F, Oltolini A, Cannistraci R, Bianconi E, Villa M, Pizzi M, Pizzi P, Manzoni G, Lattuada G, Perseghin G.Diabetes Metab Res Rev. 2021 Mar;37(3):e3389. doi: 10.1002/dmrr.3389. Epub 2020 Sep 1.PMID: 32738094
- Metabolic and Psychological Features are Associated with Weight Loss 12 Months After Sleeve Gastrectomy.
Muraca E, Oltolini A, Binda A, Pizzi M, Ciardullo S, Manzoni G, Zerbini F, Bianconi E, Cannistraci R, Perra S, Pizzi P, Lattuada G, Perseghin G, Villa M.J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3087-e3097. doi: 10.1210/clinem/dgab161.PMID: 33705552
- Baseline TSH levels and short-term weight loss after different procedures of bariatric surgery.
Muraca E, Oltolini A, Pizzi M, Villa M, Manzoni G, Perra S, Zerbini F, Bianconi E, Cannistraci R, Ciardullo S, Pizzi P, Lattuada G, Perseghin G.Int J Obes (Lond). 2021 Feb;45(2):326-330. doi: 10.1038/s41366-020-00665-6. Epub 2020 Sep 1.PMID: 32873912
- NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population.
Ciardullo S, Muraca E, Zerbini F, Manzoni G, Perseghin G.J Clin Endocrinol Metab. 2021 Jul 13;106(8):e2856-e2865. doi: 10.1210/clinem/dgab262.PMID: 33878156
- Current type 2 diabetes, rather than previous gestational diabetes, is associated with liver disease in U.S. Women.
Ciardullo S, Bianconi E, Zerbini F, Perseghin G.Diabetes Res Clin Pract. 2021 Jul;177:108879. doi: 10.1016/j.diabres.2021.108879. Epub 2021 May 29.PMID: 34058299
- Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy.
Ciardullo S, Zerbini F, Perra S, Muraca E, Cannistraci R, Lauriola M, Grosso P, Lattuada G, Ippoliti G, Mortara A, Manzoni G, Perseghin G.J Endocrinol Invest. 2021 Apr;44(4):843-850. doi: 10.1007/s40618-020-01382-7. Epub 2020 Aug 10.PMID: 32776197 Free PMC article.
- Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G, Bonfanti R, Bozzetto L, Di Blasi V, Girelli A, Grassi G, Iafusco D, Laviola L, Rabbone I, Schiaffini R, Bruttomesso D; Italian Study Group on the Diffusion of CSII.Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):335-342. doi: 10.1016/j.numecd.2017.12.001. Epub 2017 Dec 9.PMID: 29428572
- Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.
Ciardullo S, Muraca E, Perra S, Bianconi E, Zerbini F, Oltolini A, Cannistraci R, Parmeggiani P, Manzoni G, Gastaldelli A, Lattuada G, Perseghin G.BMJ Open Diabetes Res Care. 2020 Feb;8(1):e000904. doi: 10.1136/bmjdrc-2019-000904.PMID: 32049637
- Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy.
Muraca E, Ciardullo S, Oltolini A, Zerbini F, Bianconi E, Perra S, Villa M, Cannistraci R, Castoldi G, Pizzi P, Manzoni G, Lattuada G, Perseghin G.J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgaa097. doi: 10.1210/clinem/dgaa097.PMID: 32119074
- Visit-to-visit blood pressure variability in patients with type 2 diabetes with and without previous history of cardiovascular disease.
Radaelli MG, Ciardullo S, Perra S, Cannistraci R, Bianconi E, Muraca E, Zerbini F, Manzoni G, Grassi G, Mancia G, Lattuada G, Perseghin G.J Hypertens. 2020 Sep;38(9):1737-1744. doi: 10.1097/HJH.0000000000002443.PMID: 32251199
- Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD.
Ciardullo S, Ronchetti C, Muraca E, Oltolini A, Perra S, Bianconi E, Zerbini F, Cannistraci R, Manzoni G, Gastaldelli A, Lattuada G, Perseghin G.J Endocrinol Invest. 2020 Jul;43(7):1019-1026. doi: 10.1007/s40618-020-01188-7. Epub 2020 Feb 1.PMID: 32008185
- Etiopathogenesis of Basedow's disease. Trends and current aspects.
Leporati P, Groppelli G, Zerbini F, Rotondi M, Chiovato L.Nuklearmedizin. 2015;54(5):204-10. doi: 10.3413/Nukmed-0739-15-04. Epub 2015 Aug 21.PMID: 26293122 Review.
- Poverty and immigration as a barrier to iodine intake and maternal adherence to iodine supplementation.
Magri F, Zerbini F, Gaiti M, Capelli V, Croce L, Bini S, Rigamonti AE, Fiorini G, Cella SG, Chiovato L.J Endocrinol Invest. 2019 Apr;42(4):435-442. doi: 10.1007/s40618-018-0938-5. Epub 2018 Aug 21.PMID: 30132288
- Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G, Bonfanti R, Bozzetto L, Di Blasi V, Girelli A, Grassi G, Iafusco D, Laviola L, Rabbone I, Schiaffini R, Bruttomesso D; Italian Study Group on the Diffusion of CSII.Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):335-342. doi: 10.1016/j.numecd.2017.12.001. Epub 2017 Dec 9.PMID: 29428572
- GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASE.
Magri F, Zerbini F, Gaiti M, Capelli V, Ragni A, Rotondi M, Chiovato L.Endocr Pract. 2016 Nov;22(11):1336-1342. doi: 10.4158/EP161350.OR. Epub 2016 Aug 19.PMID: 27540885
- The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.
Bartalena L, Masiello E, Magri F, Veronesi G, Bianconi E, Zerbini F, Gaiti M, Spreafico E, Gallo D, Premoli P, Piantanida E, Tanda ML, Ferrario M, Vitti P, Chiovato L.J Endocrinol Invest. 2016 Dec;39(12):1445-1451. doi: 10.1007/s40618-016-0516-7. Epub 2016 Jul 27.PMID: 27465670
- Maximal stiffness evaluation by real-time ultrasound elastography, an improved tool for the differential diagnosis of thyroid nodules.
Magri F, Chytiris S, Zerbini F, Capelli V, Gaiti M, Carbone A, Fonte R, Malovini A, Rotondi M, Bellazzi R, Chiovato L.Endocr Pract. 2015 May;21(5):474-81. doi: 10.4158/EP14504.OR. Epub 2015 Feb 9.PMID: 25667375
- Comparison of elastographic strain index and thyroid fine-needle aspiration cytology in 631 thyroid nodules.
Magri F, Chytiris S, Capelli V, Gaiti M, Zerbini F, Carrara R, Malovini A, Rotondi M, Bellazzi R, Chiovato L.J Clin Endocrinol Metab. 2013 Dec;98(12):4790-7. doi: 10.1210/jc.2013-2672. Epub 2013 Sep 24.PMID: 24064692
- Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
Magri F, Schena L, Capelli V, Gaiti M, Zerbini F, Brambilla E, Rotondi M, De Amici M, Spinillo A, Nappi RE, Chiovato L.Reprod Biol Endocrinol. 2015 Sep 21;13(1):106. doi: 10.1186/s12958-015-0103-3.PMID: 26391773
- ER-alpha and ER-beta expression in differentiated thyroid cancer: relation with tumor phenotype across the TNM staging and peri-tumor inflammation.
Magri F, Capelli V, Gaiti M, Villani L, Zerbini F, La Manna L, Rotondi M, Chiovato L.Endocrine. 2015 Jun;49(2):429-35. doi: 10.1007/s12020-014-0457-x. Epub 2014 Oct 22.PMID: 25338203
- Migration flows affect women's dietary iodine intake and jeopardize their iodine sufficiency: a pilot study.
Magri F, Zerbini F, Gaiti M, Capelli V, Rotondi M, Ibañez MM, Chiovato L.Endocrine. 2017 Apr;56(1):205-207. doi: 10.1007/s12020-016-0935-4. Epub 2016 Mar 26.PMID: 27017338 No abstract available.
- A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity.
Rotondi M, Cappelli C, Leporati P, Chytiris S, Zerbini F, Fonte R, Magri F, Castellano M, Chiovato L.Eur J Endocrinol. 2010 Jul;163(1):105-9. doi: 10.1530/EJE-10-0288. Epub 2010 May 7.PMID: 20453114
- Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion.
Rotondi M, Batocchi AP, Coperchini F, Caggiula M, Zerbini F, Sideri R, Leporati P, Nociti V, Frisullo G, Mirabella M, Magri F, Oliviero A, Chiovato L.Neuroimmunomodulation. 2013;20(6):341-7. doi: 10.1159/000353567. Epub 2013 Aug 30.PMID: 24008588
- Interferon-β but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: a clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs. Rotondi M, Stufano F, Lagonigro MS, La Manna L, Zerbini F, Ghilotti S, Pagliari MT, Coperchini F, Magri F, Bergamaschi R, Oliviero A, Chiovato L.J Neuroimmunol. 2011 May;234(1-2):161-4. doi: 10.1016/j.jneuroim.2011.01.013. Epub 2011 Mar 2.PMID: 21371758